Skip to main content
. 2014 May 6;109(7):1041–1051. doi: 10.1038/ajg.2014.104

Figure A3.

Figure A3

Time to relapse (Simple Clinical Colitis Activity Index (SCCAI) ≥5) in the responder group after discontinuation of the study medication. A total of 69 patients who had a time to clinical relapse or information on censoring related to clinical relapse were included in the analysis. Patients treated with LT-02 relapsed later and less frequently than placebo patients (preplanned, two-sided log-rank test, P=0.016).